Pharma Giants Halt Investments in Germany Over Berlin's Austerity Measures, Government Defends Stance

Pharmaceutical companies Boehringer Ingelheim and Eli Lilly have announced a halt to significant investments in Germany, citing austerity directives from Berlin. The German government has since defended its course of action in response to the companies' decision.